Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
antisense therapeutics
|
| gptkbp:foundedIn |
1989
|
| gptkbp:founder |
gptkb:Stanley_T._Crooke
|
| gptkbp:headquartersLocation |
gptkb:Carlsbad,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Isis Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Spinraza
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:renamed |
gptkb:Ionis_Pharmaceuticals
2015 |
| gptkbp:stockSymbol |
gptkb:IONS
|
| gptkbp:website |
https://www.ionispharma.com/
|
| gptkbp:bfsParent |
gptkb:Ionis_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|